The Schwabe Group has acquired a majority stake in Braineffect, aiming for full ownership to enhance its presence in the growing dietary supplement market.

Target Company Overview

The Schwabe Group, a family-owned enterprise with a global presence, has executed a majority acquisition of Braineffect, a Berlin-based provider of dietary supplements and functional foods. Established in Leipzig in 1866, Schwabe specializes in the research, development, production, and distribution of phytotherapeutic and homeopathic medicines, along with supplements. With over 150 years of operation, the company currently employs approximately 4,000 individuals worldwide, of which around 1,600 are based in Germany. The headquarters is located in Karlsruhe.

Braineffect, founded in 2016 by former professional athlete Fabian Foelsch, focuses on creating scientifically backed formulations with natural ingredients. Their products are available through the company’s online shop and in retail outlets such as dm and Budni across Germany.

Industry Overview in Germany

The dietary supplement industry in Germany is experiencing significant growth, driven by increasing consumer awareness of health and wellness. This sector has seen a rising trend in the acceptance and demand for natural